ZTOX Insights

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Dividend

Dividend Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share. Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Dividend

Dividend Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share. Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Dividend

Dividend Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share. Concord Biotech Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 7.55 per equity share.

Read article

JOINDRE

JOINDRE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Joindre Capital Services (JOINDRE): Corp. Action

Corp. Action Pursuant to regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we hereby inform the exchange that the Board of Directors of the Company at its meeting held on Friday, 29th May, 2026, has inter alia, considered and approved: Dividend: The Board has recommended a final dividend of Rs. 2 per equity share having face value of Rs. 10 each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuing A

Read article

JOINDRE

JOINDRE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Joindre Capital Services (JOINDRE): Corp. Action

Corp. Action Pursuant to regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we hereby inform the exchange that the Board of Directors of the Company at its meeting held on Friday, 29th May, 2026, has inter alia, considered and approved: Dividend: The Board has recommended a final dividend of Rs. 2 per equity share having face value of Rs. 10 each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuing A

Read article

JOINDRE

JOINDRE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Joindre Capital Services (JOINDRE): Corp. Action

Corp. Action Pursuant to regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we hereby inform the exchange that the Board of Directors of the Company at its meeting held on Friday, 29th May, 2026, has inter alia, considered and approved: Dividend: The Board has recommended a final dividend of Rs. 2 per equity share having face value of Rs. 10 each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuing A

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Outcome of Board Meeting

Outcome of Board Meeting Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

CONCORDBIO

CONCORDBIO

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Outcome of Board Meeting

Outcome of Board Meeting Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

NAZARA

NAZARA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Nazara Technologies (NAZARA): Updates

Updates Nazara Technologies Limited informs the Exchange regarding Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update on Investment by Wholly-Owned Subsidiary of the Company . Nazara Technologies Limited informs the Exchange regarding Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update on Investment by Wholly-Owned Subsidiary of the Company .

Read article

NAZARA

NAZARA

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Nazara Technologies (NAZARA): Updates

Updates Nazara Technologies Limited informs the Exchange regarding Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update on Investment by Wholly-Owned Subsidiary of the Company . Nazara Technologies Limited informs the Exchange regarding Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update on Investment by Wholly-Owned Subsidiary of the Company .

Read article

INDOUS

INDOUS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Indo Us Bio-Tech (INDOUS): Outcome of Board Meeting

Outcome of Board Meeting Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

INDOUS

INDOUS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Indo Us Bio-Tech (INDOUS): Outcome of Board Meeting

Outcome of Board Meeting Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

SHIVAGR

SHIVAGR

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Shivagrico Implements (SHIVAGR): Company Update

Company Update Non Applicability of Regulation 24 A of SEBI(LODR) Regulations 2015 to listed entities who have claimed exemption under regulation 15(2) of SEBI (LODR) Regulations 2015. The Equity share capital of the company is Rs. 501.36 lakhs and Net worth is Rs. 785.69 lakhs Non Applicability of Regulation 24 A of SEBI(LODR) Regulations 2015 to listed entities who have claimed exemption under regulation 15(2) of SEBI (LODR) Regulations 2015. The Equity share capital of the company is Rs. 50

Read article